Biotechnology
Ardea Biosciences, Inc. today announced that it has earned a $7.5 million milestone from Bayer HealthCare under the terms of their April 2009 global license agreement to develop and commercialize Ardea's mitogen-activated ERK kinase inhibitor ...
0 minutes ago
Bilcare and CSIR to Partner on nonClonableID Technology for Authentication of Drugs
7 minutes ago
Ingen Technologies, Inc. announced today that it has agreed to execute a Plan of Reorganization that would include reductions in debt and liabilities, various merger/acquisition proposals, new medical product distribution programs and finally, ...
15 minutes ago
Puma Biotechnology, Inc. , a development stage biopharmaceutical company, announced that Alan H. Auerbach, its Chairman, Chief Executive Officer, President and Founder, will present an overview of the Company at 9:30 a.m. EDT on Wednesday, June 6, ...
17 minutes ago
Reaxys Announces Finalists of the 2012 Reaxys PhD Prize
25 minutes ago
Infinity Pharmaceuticals, Inc. will be presenting at the Jefferies 2012 Global Healthcare Conference on June 6, 2012, at 3:00 p.m. ET in New York City.
27 minutes ago
Ember Therapeutics, Inc., a company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease, today announced the appointment of Jasbir Seehra, Ph.D., to chief scientific officer; ...
27 minutes ago
InterMune To Present At The Goldman Sachs 33rd Annual Global Healthcare Conference
28 minutes ago
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the colorectal cancer drug market in Russia will grow 3 percent annually to $487 million in 2016. According to ...
28 minutes ago
Accelrys, Inc. , a leading enterprise R&D software and services company, today announced that the Gulf Coast Consortia for Quantitative Biomedical Sciences has signed a five-year licensing agreement with Accelrys to provide investigators in the ...
29 minutes ago
Insmed Incorporated , a biopharmaceutical company, today provided a corporate update, including the Company's current strategic development priorities for ARIKACE® .
29 minutes ago
Merck , known as MSD outside the United States and Canada, announced today that Kenneth C. Frazier, Merck's chairman and chief executive officer is scheduled to present at the Sanford C. Bernstein 28th Strategic Decisions Conference in New York ...
29 minutes ago
Dyax Corp. announced today, based on successful antibody discovery work during a research evaluation period, Bayer Pharma AG has executed a license to Dyax's antibody phage display technology for development and potential commercialization of ...
29 minutes ago
Cytori Therapeutics has obtained approval to sell the Celution® 800 System in Russia for various medical uses. These clinical uses are based on those in the current European CE Mark, and include the use of the Celution® system and its ...
29 minutes ago
Celsion Corporation , a leading oncology drug development company, today announced that it has reached its enrollment objective of 700 patients in the Company's pivotal, Phase III HEAT Study, a multinational, randomized, double-blind, placebo-...
30 minutes ago
Synta Pharmaceuticals Corp. today announced that the Company will be presenting at the Jefferies 2012 Global Healthcare Conference on Wednesday, June 6 at 4:30 p.m. in New York.
35 minutes ago
ARIAD Pharmaceuticals, Inc. today announced that Harvey J. Berger, M.D., chairman and chief executive officer, and Timothy P. Clackson, Ph.D., president of research and development and chief scientific officer, will provide an overview of the ...
55 minutes ago
AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, announced today that it has obtained commitments from ...
59 minutes ago
PROLOR Biotech, Inc. , a clinical stage company developing next generation biobetter therapeutic proteins, today announced that company management will give a corporate presentation at the Jefferies 2012 Global Health Care Conference, being held at ...
59 minutes ago
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management ...
59 minutes ago
1 - 20 of 53035 Stories
<<
<
Next 20 Biotechnology
>
>>
Search News
